(S)-AMPA increases activity ISO RGD:2050 6480464 alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid results in increased activity of ADORA2B protein CTD PMID:16601261 (S)-AMPA multiple interactions ISO RGD:2050 6480464 [isoalloxazine binds to and results in decreased activity of ADORA2B protein] which results in decreased susceptibility to alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid, isoalloxazine inhibits the reaction [alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid results in increased activity of ADORA2B protein] CTD PMID:16601261 (S)-amphetamine decreases expression EXP 6480464 Dextroamphetamine results in decreased expression of ADORA2B mRNA CTD PMID:12205029 (S)-amphetamine multiple interactions EXP 6480464 SOD1 inhibits the reaction [Dextroamphetamine results in decreased expression of ADORA2B mRNA] CTD PMID:12205029 1,7-dimethylxanthine multiple interactions ISO RGD:731019 6480464 ADORA2B mutant form inhibits the reaction [1 more ... CTD PMID:22701600 1-chloro-2,4-dinitrobenzene increases expression ISO RGD:731019 6480464 Dinitrochlorobenzene results in increased expression of ADORA2B mRNA CTD PMID:16314067 17beta-estradiol multiple interactions ISO RGD:731019 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of ADORA2B mRNA, Estradiol promotes the reaction [ESR2 protein results in decreased expression of ADORA2B mRNA] CTD PMID:20404318 , PMID:30165855 17beta-estradiol multiple interactions ISO RGD:2050 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of ADORA2B mRNA CTD PMID:26496021 17beta-estradiol multiple interactions EXP 6480464 [Estradiol co-treated with Progesterone] results in increased expression of ADORA2B mRNA CTD PMID:19693291 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:731019 6480464 [Tetrachlorodibenzodioxin co-treated with Cycloheximide] results in increased expression of ADORA2B mRNA CTD PMID:19684285 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of ADORA2B mRNA CTD PMID:21570461 , PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:2050 6480464 Tetrachlorodibenzodioxin results in decreased expression of ADORA2B mRNA CTD PMID:21724226 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:2050 6480464 Tetrachlorodibenzodioxin affects the expression of ADORA2B mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:731019 6480464 Tetrachlorodibenzodioxin results in increased expression of ADORA2B mRNA CTD PMID:19684285 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:731019 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ADORA2B mRNA CTD PMID:28628672 3H-1,2-dithiole-3-thione increases expression ISO RGD:2050 6480464 1, 2-dithiol-3-thione results in increased expression of ADORA2B mRNA CTD PMID:19162173 4-hydroxynon-2-enal decreases expression EXP 6480464 4-hydroxy-2-nonenal results in decreased expression of ADORA2B mRNA CTD PMID:19191707 4-hydroxyphenyl retinamide increases expression EXP 6480464 Fenretinide results in increased expression of ADORA2B mRNA CTD PMID:28973697 4-tert-butylphenol increases expression ISO RGD:731019 6480464 butylphen results in increased expression of ADORA2B mRNA CTD PMID:10571726 acetamide increases expression ISO RGD:2050 6480464 acetamide results in increased expression of ADORA2B mRNA CTD PMID:31881176 acrylamide increases expression ISO RGD:2050 6480464 Acrylamide results in increased expression of ADORA2B mRNA CTD PMID:28959563 adenosine affects response to substance EXP 6480464 ADORA2B protein affects the susceptibility to Adenosine CTD PMID:16920807 aflatoxin B1 affects expression ISO RGD:731019 6480464 Aflatoxin B1 affects the expression of ADORA2B protein CTD PMID:20106945 aflatoxin B1 increases expression ISO RGD:731019 6480464 Aflatoxin B1 results in increased expression of ADORA2B mRNA CTD PMID:22100608 , PMID:32234424 all-trans-retinoic acid increases expression ISO RGD:2050 6480464 Tretinoin results in increased expression of ADORA2B mRNA CTD PMID:20488242 all-trans-retinoic acid decreases expression ISO RGD:731019 6480464 Tretinoin results in decreased expression of ADORA2B mRNA CTD PMID:23724009 alloxazine multiple interactions ISO RGD:2050 6480464 [isoalloxazine binds to and results in decreased activity of ADORA2B protein] which results in decreased susceptibility to alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid more ... CTD PMID:16601261 ammonium chloride affects expression ISO RGD:2050 6480464 Ammonium Chloride affects the expression of ADORA2B mRNA CTD PMID:16483693 BAY 60-6583 multiple interactions ISO RGD:2050 6480464 BAY 60-6583 binds to and results in increased activity of ADORA2B protein CTD PMID:19749167 benzo[a]pyrene increases expression EXP 6480464 Benzoapyrene results in increased expression of ADORA2B mRNA CTD PMID:23735875 benzo[a]pyrene increases methylation ISO RGD:731019 6480464 Benzoapyrene results in increased methylation of ADORA2B promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:731019 6480464 Benzoapyrene results in increased expression of ADORA2B mRNA CTD PMID:20064835 more ... benzo[a]pyrene diol epoxide I decreases expression ISO RGD:731019 6480464 7 more ... CTD PMID:20382639 bis(2-ethylhexyl) phthalate increases expression ISO RGD:2050 6480464 Diethylhexyl Phthalate results in increased expression of ADORA2B mRNA CTD PMID:20920545 bisphenol A multiple interactions ISO RGD:2050 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of ADORA2B mRNA CTD PMID:26496021 bisphenol A decreases expression ISO RGD:2050 6480464 bisphenol A results in decreased expression of ADORA2B mRNA CTD PMID:30816183 bisphenol A multiple interactions ISO RGD:731019 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ADORA2B mRNA CTD PMID:28628672 bisphenol A increases expression ISO RGD:2050 6480464 bisphenol A results in increased expression of ADORA2B mRNA CTD PMID:25181051 bromobenzene decreases expression ISO RGD:2050 6480464 bromobenzene results in decreased expression of ADORA2B mRNA CTD PMID:32479839 butan-1-ol multiple interactions ISO RGD:731019 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of ADORA2B mRNA CTD PMID:29432896 cadmium atom increases expression ISO RGD:731019 6480464 Cadmium results in increased expression of ADORA2B mRNA CTD PMID:21172416 cadmium dichloride decreases expression ISO RGD:2050 6480464 Cadmium Chloride results in decreased expression of ADORA2B mRNA CTD PMID:25993096 caffeine multiple interactions ISO RGD:731019 6480464 ADORA2B mutant form inhibits the reaction [Caffeine results in decreased expression of and results in decreased activity of HSD11B2 protein], ADORA2B mutant form inhibits the reaction [Caffeine results in decreased expression of HSD11B2 mRNA] CTD PMID:22701600 caffeine decreases expression ISO RGD:2050 6480464 Caffeine results in decreased expression of ADORA2B mRNA CTD PMID:26367767 calcitriol multiple interactions ISO RGD:731019 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of ADORA2B mRNA CTD PMID:21592394 calcitriol decreases expression ISO RGD:731019 6480464 Calcitriol results in decreased expression of ADORA2B mRNA CTD PMID:21592394 carbon nanotube affects expression EXP 6480464 Nanotubes, Carbon affects the expression of ADORA2B mRNA CTD PMID:23845593 carbon nanotube increases expression EXP 6480464 Nanotubes more ... CTD PMID:25554681 cerium trichloride decreases expression EXP 6480464 cerous chloride results in decreased expression of ADORA2B mRNA CTD PMID:23573234 choline multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ADORA2B mRNA CTD PMID:20938992 cisplatin affects response to substance ISO RGD:731019 6480464 ADORA2B protein affects the susceptibility to Cisplatin CTD PMID:16217747 cisplatin multiple interactions ISO RGD:731019 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of ADORA2B mRNA CTD PMID:27392435 cobalt atom multiple interactions ISO RGD:731019 6480464 [tungsten carbide co-treated with Cobalt] results in increased expression of ADORA2B mRNA CTD PMID:18078969 cocaine affects expression ISO RGD:2050 6480464 Cocaine affects the expression of ADORA2B mRNA CTD PMID:20187946 copper(II) sulfate decreases expression ISO RGD:731019 6480464 Copper Sulfate results in decreased expression of ADORA2B mRNA CTD PMID:19549813 crocidolite asbestos affects expression ISO RGD:731019 6480464 Asbestos, Crocidolite affects the expression of ADORA2B mRNA CTD PMID:17331233 cycloheximide multiple interactions ISO RGD:731019 6480464 [Tetrachlorodibenzodioxin co-treated with Cycloheximide] results in increased expression of ADORA2B mRNA CTD PMID:19684285 cyclosporin A increases expression ISO RGD:731019 6480464 Cyclosporine results in increased expression of ADORA2B mRNA CTD PMID:20106945 cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of ADORA2B mRNA CTD PMID:26311998 dexamethasone multiple interactions ISO RGD:731019 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ADORA2B mRNA CTD PMID:28628672 dextran sulfate multiple interactions EXP 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] affects the expression of ADORA2B mRNA CTD PMID:29950665 diazinon increases methylation ISO RGD:731019 6480464 Diazinon results in increased methylation of ADORA2B gene CTD PMID:22964155 diclofenac increases expression EXP 6480464 Diclofenac results in increased expression of ADORA2B mRNA CTD PMID:26934552 dioxygen multiple interactions EXP 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ADORA2B mRNA CTD PMID:30529165 diquat increases expression ISO RGD:731019 6480464 Diquat results in increased expression of ADORA2B mRNA CTD PMID:21172416 dorsomorphin multiple interactions ISO RGD:731019 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... CTD PMID:27188386 DPCPX affects binding ISO RGD:731019 6480464 1, 3-dipropyl-8-cyclopentylxanthine binds to ADORA2B protein CTD PMID:21186795 entinostat multiple interactions ISO RGD:731019 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of ADORA2B mRNA CTD PMID:27188386 entinostat increases expression ISO RGD:731019 6480464 entinostat results in increased expression of ADORA2B mRNA CTD PMID:26272509 , PMID:27188386 ferric oxide increases expression EXP 6480464 ferric oxide analog results in increased expression of ADORA2B mRNA CTD PMID:25086211 folic acid multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ADORA2B mRNA CTD PMID:20938992 formaldehyde decreases expression ISO RGD:731019 6480464 Formaldehyde results in decreased expression of ADORA2B mRNA CTD PMID:20655997 furan increases expression ISO RGD:2050 6480464 furan results in increased expression of ADORA2B mRNA CTD PMID:27387713 indometacin multiple interactions ISO RGD:731019 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ADORA2B mRNA CTD PMID:28628672 isobutanol multiple interactions ISO RGD:731019 6480464 [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of ADORA2B mRNA CTD PMID:29432896 L-methionine multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ADORA2B mRNA CTD PMID:20938992 lead(0) affects expression ISO RGD:731019 6480464 Lead affects the expression of ADORA2B mRNA CTD PMID:28903495 lead(2+) affects expression ISO RGD:731019 6480464 Lead affects the expression of ADORA2B mRNA CTD PMID:28903495 lipopolysaccharide decreases expression ISO RGD:731019 6480464 Lipopolysaccharides results in decreased expression of ADORA2B mRNA CTD PMID:20067761 lipopolysaccharide increases expression EXP 6480464 Lipopolysaccharides results in increased expression of ADORA2B mRNA CTD PMID:21461237 , PMID:25890327 lipopolysaccharide multiple interactions EXP 6480464 [Lipopolysaccharides co-treated with Melatonin] results in decreased expression of ADORA2B mRNA, Melatonin inhibits the reaction [Lipopolysaccharides results in increased expression of ADORA2B mRNA] CTD PMID:21461237 MeIQx increases expression ISO RGD:731019 6480464 2-amino-3 more ... CTD PMID:20816883 melatonin multiple interactions EXP 6480464 [Lipopolysaccharides co-treated with Melatonin] results in decreased expression of ADORA2B mRNA, Melatonin inhibits the reaction [Lipopolysaccharides results in increased expression of ADORA2B mRNA] CTD PMID:21461237 melatonin decreases expression EXP 6480464 Melatonin results in decreased expression of ADORA2B mRNA CTD PMID:21461237 methotrexate increases expression ISO RGD:731019 6480464 Methotrexate results in increased expression of ADORA2B mRNA CTD PMID:22682496 modafinil increases activity ISO RGD:2050 6480464 modafinil results in increased activity of ADORA2B protein CTD PMID:29649498 N-ethyl-5'-carboxamidoadenosine affects response to substance EXP 6480464 ADORA2B protein affects the susceptibility to Adenosine-5'-N-ethylcarboxamide CTD PMID:16920807 nickel atom increases expression ISO RGD:731019 6480464 Nickel results in increased expression of ADORA2B mRNA CTD PMID:25583101 nickel sulfate increases expression ISO RGD:731019 6480464 nickel sulfate results in increased expression of ADORA2B mRNA CTD PMID:16314067 nitrogen dioxide multiple interactions ISO RGD:731019 6480464 [Air Pollutants results in increased abundance of Nitrogen Dioxide] which affects the methylation of ADORA2B gene CTD PMID:29935799 paracetamol increases expression ISO RGD:731019 6480464 Acetaminophen results in increased expression of ADORA2B mRNA CTD PMID:29067470 phenobarbital affects expression ISO RGD:731019 6480464 Phenobarbital affects the expression of ADORA2B mRNA CTD PMID:19159669 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of ADORA2B mRNA CTD PMID:17426115 progesterone multiple interactions EXP 6480464 [Estradiol co-treated with Progesterone] results in increased expression of ADORA2B mRNA CTD PMID:19693291 progesterone increases expression EXP 6480464 Progesterone results in increased expression of ADORA2B mRNA CTD PMID:19693291 propiconazole decreases expression ISO RGD:2050 6480464 propiconazole results in decreased expression of ADORA2B mRNA CTD PMID:19423681 raloxifene multiple interactions ISO RGD:731019 6480464 [Raloxifene Hydrochloride co-treated with ESR2 protein] results in increased expression of ADORA2B mRNA CTD PMID:19059307 rotenone decreases expression ISO RGD:2050 6480464 Rotenone results in decreased expression of ADORA2B mRNA CTD PMID:28374803 rotenone increases expression ISO RGD:731019 6480464 Rotenone results in increased expression of ADORA2B mRNA CTD PMID:29955902 SB 431542 multiple interactions ISO RGD:731019 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... CTD PMID:27188386 sodium dichromate decreases expression ISO RGD:2050 6480464 sodium bichromate results in decreased expression of ADORA2B mRNA CTD PMID:25993096 succimer multiple interactions EXP 6480464 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of ADORA2B mRNA CTD PMID:21641980 sulforaphane increases expression ISO RGD:731019 6480464 sulforafan results in increased expression of ADORA2B mRNA CTD PMID:31838189 sunitinib increases expression ISO RGD:731019 6480464 Sunitinib results in increased expression of ADORA2B mRNA CTD PMID:31533062 tamoxifen multiple interactions ISO RGD:731019 6480464 [Tamoxifen co-treated with ESR2 protein] results in increased expression of ADORA2B mRNA CTD PMID:19059307 tert-butyl hydroperoxide increases expression ISO RGD:731019 6480464 tert-Butylhydroperoxide results in increased expression of ADORA2B mRNA CTD PMID:15336504 testosterone decreases expression ISO RGD:731019 6480464 Testosterone results in decreased expression of ADORA2B mRNA CTD PMID:21592394 testosterone increases expression EXP 6480464 Testosterone results in increased expression of ADORA2B mRNA CTD PMID:19693291 testosterone multiple interactions ISO RGD:731019 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of ADORA2B mRNA CTD PMID:21592394 tetrachloroethene increases expression EXP 6480464 Tetrachloroethylene results in increased expression of ADORA2B mRNA CTD PMID:28973375 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of ADORA2B mRNA CTD PMID:17484886 , PMID:18263696 tetrachloromethane increases expression ISO RGD:2050 6480464 Carbon Tetrachloride results in increased expression of ADORA2B mRNA CTD PMID:31150632 titanium dioxide multiple interactions EXP 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] affects the expression of ADORA2B mRNA CTD PMID:29950665 tremolite asbestos increases expression EXP 6480464 tremolite results in increased expression of ADORA2B mRNA CTD PMID:29279043 triadimefon decreases expression ISO RGD:2050 6480464 triadimefon results in decreased expression of ADORA2B mRNA CTD PMID:19423681 trichloroethene increases methylation ISO RGD:2050 6480464 Trichloroethylene results in increased methylation of ADORA2B gene CTD PMID:27618143 trimellitic anhydride increases expression EXP 6480464 trimellitic anhydride results in increased expression of ADORA2B mRNA CTD PMID:19042947 Tungsten carbide multiple interactions ISO RGD:731019 6480464 [tungsten carbide co-treated with Cobalt] results in increased expression of ADORA2B mRNA CTD PMID:18078969 tunicamycin decreases expression ISO RGD:731019 6480464 Tunicamycin results in decreased expression of ADORA2B mRNA CTD PMID:22378314 valproic acid increases methylation ISO RGD:731019 6480464 Valproic Acid results in increased methylation of ADORA2B gene CTD PMID:29154799 valproic acid multiple interactions ISO RGD:731019 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of ADORA2B mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:731019 6480464 Valproic Acid results in increased expression of ADORA2B mRNA CTD PMID:24383497 , PMID:26272509 valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of ADORA2B mRNA CTD PMID:17963808 vinclozolin increases expression ISO RGD:2050 6480464 vinclozolin results in increased expression of ADORA2B mRNA CTD PMID:15686871